Trevena Inc (TRVN) Just Got Its Billion Dollar Pain Management Bid Underway

Trevena Inc (NASDAQ:TRVN) just kicked off a two concurrent phase III pivotals in its lead pain management candidate, Oliceridine.

Keep Reading →